FY 2019 Annual Statement to the Appropriations Committee ______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s Fiscal Year (FY) 2019 budget request for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH). NIAMS RESEARCH

September 19, 2018 Fiscal Year 2017 Actual Obligations* Budget Mechanism No. of Awards Amount Research Grants Research Project Grants (RPG): Noncompeting 663 $250,247,112 Administrative Supplements (30) 3,071,421 Competing 272 97,655,299 Subtotal 935 350,973,832 Small Business Innovation/Technology 39 16,839,866 Subtotal, RPGs 974 367,813,698 Research Centers 42 44,760,125 Other Research: Career Programs

Provides avenues to advance the methodological sciences that support clinical research within and across the NIAMS’ portfolio of diseases. These FAQs apply to the following funding opportunity: Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed): RFA-AR-24-003 Core Design

NIAMS FY 2019 Enacted Level: $605,065,000 The NIAMS is operating under the FY 2019 Department of Defense and Labor, Health and Human Services, and Education Appropriations Act. The interim funding plan below for research and training grants represents the most current information as of the date cited above; however, many

August 30, 2017 The decision to fund or not to fund a particular application is based on the assessment of scientific merit by a peer review group and on the relevance of the proposed work to the Institute's scientific and health priorities. Peer reviewers' judgments of scientific merit are expressed

August 27, 2018 NIAMS FY 2018 Enacted Level: $586,661,000 The NIAMS is operating under the FY 2018 Omnibus Appropriations bill. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect